Do you know when Paxlovid should be used to treat COVID-19? Are you aware of the reasons for the mixed results of its phase 2 and phase 3 clinical trial data versus its real-life studies? Do you know what the most significant concern about Paxlovid is for its future application in treating COVID-19? Reputed as…
9 Things You Need to Know About Paxlovid
February 9, 2023
admin
antiviral drugantiviral pillCCP VirusCoronavirus In-DepthCOVID-19nirmatrelvir–ritonavirPaxlovidPF-07321332Uncategorized
0 Comment
A Deep Dive Into Oral Antiviral Pills for COVID (Part 1)
February 6, 2023
admin
antiviral drugantiviral pillCCP VirusCoronavirus In-DepthCOVID-19nirmatrelvir–ritonavirPaxlovidPF-07321332Uncategorized
0 Comment
As the world figures out how to coexist with COVID-19, the introduction of oral pills looks promising, in addition to the treatments of monoclonal antibodies and remdesivir. In this multiple series of articles, we will review three oral antivirals against COVID: Paxlovid developed by Pfizer, molnupiravir developed by Merck, and Azvudine developed by Genuine Biotech…
Hong Kong Study of Oral Antivirals Shows Promise for Omicron Patients
A study conducted by Hong Kong University (HKU) Medical School found that two oral drugs, molnupiravir and ritonavir-boosted nirmatrelvir, could reduce the risk of death in COVID-19 patients if used at the early stage of hospital admission. Molnupiravir reduced the risk of all-cause death by 52 percent, while a 66 percent reduction was observed with…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`